DJ-1 as a Novel Therapeutic Target for Mitigating Myocardial Ischemia–Reperfusion Injury
2024

DJ-1 as a Therapeutic Target for Heart Injury

publication Evidence: moderate

Author Information

Author(s): Zhou Jia-Bin, Wei Tian-Peng, Wu Dan, Zhou Feng, Wang Ru-Xing

Primary Institution: Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center Nanjing Medical University, Wuxi 214023, China

Hypothesis

Can DJ-1 be used as a therapeutic target to protect the heart from ischemia-reperfusion injury?

Conclusion

DJ-1 has protective properties that can help mitigate damage from myocardial ischemia-reperfusion injury.

Supporting Evidence

  • DJ-1 is involved in protecting the heart from oxidative stress and inflammation during ischemia-reperfusion injury.
  • Research shows that DJ-1 can enhance the stability of antioxidant proteins, helping to reduce cellular damage.
  • DJ-1's ability to regulate autophagy is crucial for maintaining heart cell health during stress.
  • Exogenous administration of DJ-1 has been shown to protect against myocardial infarction in animal models.

Takeaway

DJ-1 is a special protein that helps protect the heart when it gets hurt from a lack of blood. Scientists think it could help make new medicines to keep hearts safe.

Methodology

This review summarizes current knowledge of DJ-1's role in protecting the heart during ischemia and reperfusion.

Limitations

The precise mechanisms of DJ-1's cardioprotective effects are not fully documented, and delivery to the heart remains challenging.

Digital Object Identifier (DOI)

10.1155/cdr/6615720

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication